KRAS and BRAF mutational status in colon cancer from Albanian patients

被引:0
作者
Daniela Martinetti
Rosario Costanzo
Shahin Kadare
Mehdiu Alimehmeti
Cristina Colarossi
Vincenzo Canzonieri
Massimiliano Berretta
Lorenzo Memeo
机构
[1] IOM Ricerca Srl,Department of Pathology
[2] Morphopathology Laboratories,Department of Experimental Oncology
[3] University of Tirana,Division of Pathology
[4] Mediterranean Institute of Oncology,Department of Clinical Oncology
[5] Centro di Riferimento Oncologico,undefined
[6] Centro di Riferimento Oncologico,undefined
来源
Diagnostic Pathology | / 9卷
关键词
Colorectal cancer; KRAS; BRAF; Albania;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] The interplay of KRAS mutational status with tumor laterality in non-metastatic colorectal cancer: An international, multi-institutional study in patients with known KRAS, BRAF, and MSI status
    Kamphues, Carsten
    Kadowaki, Shigenori
    Amini, Neda
    van den Berg, Inge
    Wang, Jaeyun
    Andreatos, Nikolaos
    Sakamoto, Yuki
    Ogura, Toshiro
    Kakuta, Miho
    Pikouli, Anastasia
    Geka, Despoina
    Daitoku, Nobuya
    Theochari, Maria
    Buettner, Stefan
    Akiyama, Takahiko
    Antoniou, Efstathios
    Pikoulis, Emmanouil
    Theodoropoulos, George
    Imai, Katsunori
    Ijzermans, Jan N. M.
    Margonis, Georgios A.
    Akagi, Kiwamu
    Kreis, Martin E.
    JOURNAL OF SURGICAL ONCOLOGY, 2021, 123 (04) : 1005 - 1014
  • [22] KRAS and BRAF mutations and MSI status in precursor lesions of colorectal cancer detected by colonoscopy
    Yamane, L. S.
    Scapulatempo-Neto, C.
    Alvarenga, L.
    Oliveira, C. Z.
    Berardinelli, G. N.
    Almodova, E.
    Cunha, T. R.
    Fava, G.
    Colaiacovo, W.
    Melani, A.
    Fregnani, J. H.
    Reis, R. M.
    Guimaraes, D. P.
    ONCOLOGY REPORTS, 2014, 32 (04) : 1419 - 1426
  • [23] Combined mutational analysis of KRAS, NRAS and BRAF genes in Indian patients with colorectal carcinoma
    Bagadi, Sarita B.
    Sanghvi, Meera
    Nair, Sudish B.
    Das, Bibhu R.
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2012, 27 (01) : 27 - 33
  • [24] The prognostic significance of KRAS and BRAF mutation status in Korean colorectal cancer patients
    Daeyoun David Won
    Jae Im Lee
    In Kyu Lee
    Seong-Taek Oh
    Eun Sun Jung
    Sung Hak Lee
    BMC Cancer, 17
  • [25] The prognostic significance of KRAS and BRAF mutation status in Korean colorectal cancer patients
    Won, Daeyoun David
    Lee, Jae Im
    Lee, In Kyu
    Oh, Seong-Taek
    Jung, Eun Sun
    Lee, Sung Hak
    BMC CANCER, 2017, 17
  • [26] KRAS, BRAF and gastric cancer
    Hewitt, Lindsay C.
    Hutchins, Gordon G.
    Melotte, Veerle
    Saito, Yuichi
    Grabsch, Heike I.
    TRANSLATIONAL GASTROINTESTINAL CANCER, 2015, 4 (06) : 429 - 447
  • [27] Distribution of some activating KRAS and BRAF mutations in Slovene patients with colorectal cancer
    Licar, Alenka
    Cerkovnik, Petra
    Novakovic, Srdjan
    MEDICAL ONCOLOGY, 2011, 28 (04) : 1048 - 1053
  • [28] KRAS, BRAF, EGFR and HER2 gene status in a Spanish population of colorectal cancer
    Herreros-Villanueva, Marta
    Rodrigo, Maximiliano
    Claver, Manuel
    Muniz, Pilar
    Lastra, Enrique
    Garcia-Giron, Carlos
    Jesus Coma del Corral, Maria
    MOLECULAR BIOLOGY REPORTS, 2011, 38 (02) : 1315 - 1320
  • [29] Molecular pathological epidemiology of colorectal cancer in Chinese patients with KRAS and BRAF mutations
    Li, Wenbin
    Qiu, Tian
    Ling, Yun
    Guo, Lei
    Li, Lin
    Ying, Jianming
    ONCOTARGET, 2015, 6 (37) : 39607 - 39613
  • [30] Analysis of KRAS, BRAF, and EGFR mutational status in respiratory epithelial adenomatoid hamartoma (REAH)
    Guimaraes, Leticia Martins
    Vieira, Tamara da Silva
    De Marco, Luiz Armando
    Thompson, Lester D. R.
    Gomes, Carolina Cavalieri
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2023, 52 (06) : 548 - 553